challenge the status quo for the better. Chiesi Global Rare Diseases Chiesi Global Rare Diseases is a Chiesi Group... support services for rare and ultra-rare disorders, many of whom have limited or no treatments available. This unit is based...
role will be the liaison between the field, Rare Disease leadership and home office cross-functional partners as well... as any external vendors to support the on-going development and operational needs across the rare disease portfolio for the family...
you and empower you? Join us as a Rare Disease Business Manager – Primary Immune Deficiency and CIDP. As part of the PI/CIDP Sales... sales experience, preferably in rare disease. Sales experience with pharmaceutical or biologic products requiring...
Make your mark for patients We are looking for a Finance Business Partner (Rare Disease) who is strategically minded...
is accessible to you. Company will not sponsor visas for this position. The Ultra‑Rare Disease Territory Account Specialist... patient outcomes. Operating with autonomy in a highly dynamic environment, the Ultra‑Rare Disease Territory Account Specialist...
as they navigate their rare disease journey Develop and execute comprehensive patient programming strategies that prioritize patient... and caregivers on behalf of Alexion per approved policy Build the rare disease network/relationships through local advocacy groups...
to support development decisions in rare disease programs. This role serves as the scientific and strategic owner of QSP...-impact rare disease programs, particularly those requiring integration across biomarkers, disease progression, and regulatory...
environments. Background in Medical Affairs or Rare Disease marketing is a strong plus. Required Experience 7-10 years...
. Background in Medical Affairs or Rare Disease marketing is a strong plus. Required Experience 7 10 years of omnichannel...
Job title: Rare Blood Disorder - CABLIVI Institutional Account Director (IAD), Ohio/PA West Location: Ohio... or Pennsylvania W About the Job Sanofi is rapidly building momentum with the execution of its Rare Blood Disorders strategy...